02. Narrow Complex Tachycardia

Definition

HR>100 with a QRS duration <0.12 sec (120 ms), can be regular or irregular. Given their narrow QRS duration they originate above the ventricle and are commonly referred to as a supraventricular tachycardia (SVT). An SVT may also have a wide QRS when there is aberrant conduction. Tachycardia is classified as regular or irregular and narrow complex or wide complex.

Differential diagnosis

Regular

Irregular

Atrial activity on EKG

  • Sinus tachycardia
  • Atrial tachycardia
  • Atrial flutter with regular block

Atrial activity might be buried on EKG

  • A-V nodal reentry (AVNRT)

Accessory-pathway mediated reentry (aka: AVRT, Wolf-Parkinson-White)

No atrial activity on EKG

  • Junctional tachycardia
  • Sinus Tachycardia with respiratory variation (p-waves visible)
  • Atrial Fibrillation
  • Atrial Flutter with variable block
  • Multifocal atrial tachycardia (MAT)
  • Frequent premature atrial complexes (PACs)

See below for additional details for each.

Evaluation

  • Obtain 12-lead ECG and full set of vital signs to determine hemodynamic stability.
  • If unstable or showing signs of rate related cardiovascular compromise (chest pain, altered mental status, hypotension or other signs of shock), follow ACLS unstable SVT protocols.
  • Compare current ECG to prior 12- lead ECG. Remember to evaluate for evidence of delta waves (WPW) when at a slower rate as this will affect management (see below).

Management

  • If unstable, follow ACLS protocol and do not delay synchronized cardioversion.
  • Tailor treatment to the type of narrow complex tachycardia (see below).
  • To break an SVT, can try vagal maneuvers or adenosine:
  • Vagal maneuvers: Can often break SVT
    • Valsalva maneuver: bear down as if to have a bowel movement, or blow into an empty syringe; hold for 15 seconds.
    • Modified Valsalva maneuver (shown to be more effective in breaking SVT): after the above, lay the patient flat and passively raise the legs to 45 degrees for 15 seconds (for video demonstration, see https://www.youtube.com/watch?v=namIRl1we2g).
    • Carotid Massage: stimulates baroreceptors that trigger a reflexive increase in vagal activity and slowing conduction through the AV node.  Place firm pressure to the neck at the level of the cricoid cartilage for 5 sec with circular motion. Prior to doing so, auscultate for carotid bruits. If present, do not perform this procedure.
  • Adenosine:
    • Warn patients that adenosine will make them feel terrible but it will be short (a few seconds). Be aware that you may see several seconds of asystole before a rhythm resumes.
    • Dosing and administration
    • Peripheral IV: 6mg X1, may repeat a second 6mg dose several minutes later if not in sinus rhythm, then increase to 12mg dose X1.
    • Central Line: lower doses of 3mg with a repeat dose and then increased dose of 6mg.
    • Continuous ECG monitoring during administration to evaluate for the underlying rhythm.
    • Rapid IV flush is required due to very short half-life.
    • Adverse Reactions: bronchospasm, ventricular fibrillation (VF, very rare), chest pain and dyspnea (more common).
  • 60-80% of patients treated with a 6mg dose of adenosine will break their SVT and 90-95% will break with a dose of 12mg.
  • If the rhythm doesn’t break, it often will slow enough to reveal the underlying rhythm such as atrial flutter or atrial tachycardia.
  • AVOID IN: severe COPD
  • DO NOT USE INHeart transplant recipients (causes prolonged asystole), wide complex tachycardia (unless SVT with aberrancy is certain, causes VF), and WPW (causes rapid ventricular rate and can degrade to VF, treat with procainamide if occurs), previous allergy.
  • Rate control agents: see Cardiology: Atrial fibrillation. 

Six Main Causes of Regular Narrow Complex Tachycardia

Sinus tachycardia (ST): When cardiac function is compromised, the cardiac output may be dependent on the HR due to a fixed stroke volume (SV). Always look for an underlying etiology.

  • Causes:  physiologic response to a stress on the body and is often the marker of an underlying illness:
  • Infection, fever, pain, hypovolemia, hypotension
  • Pulmonary embolism, hypoxia
  • Cardiac tamponade, pericarditis
  • Metabolic conditions: hyperthyroidism
  • Alcohol withdrawal
  • Response to sympathomimetic drugs (i.e.: vasopressors, bronchodilators, beta agonists)
  • Diagnosis: p-waves on EKG and during adenosine push. Upright in leads I and II, and biphasic in V1. Maximum HR of a normal individual is 220 minus age.
  • Treatment: treat the underlying cause. Avoid beta-blockade except in rare circumstances.

Atrial tachycardia (AT):

  • Causes: paroxysmal in nature and is caused by a focus of enhanced automaticity within the atria or a focus of an ectopic atrial pacemaker. 
  • Diagnosis:  Can be difficult to diagnose. Rate usually <250bpm, will have non-sinus p-waves (not biphasic in V1, not upright in II, and III) on rhythm strip and may require adenosine (see below) to diagnose. Onset is typically with a premature atrial contraction (you may see a deformed T-wave which reflects a P-wave superimposed on the T-wave).

Atrial flutter with regular block:

  • Causes: reentrant circuit within atrium.
  • Diagnosis: classic “saw-tooth” p-wave which typically has a rate of ~300 bpm. The ventricular rate is determined by the rate of conduction block (often 2:1 at 150 bpm). Slowing of the atrial flutter rate (down to 110 bpm) can be seen when patients are on amiodarone or other anti-arrhythmics.

A-V nodal reentry tachycardia (AVNRT):

  • Causes: dual conduction pathway within the A-V node itself, typically one that conducts fast and one that conducts slowly. AVNRT is usually set off by a premature atrial contraction (PAC).
  • Diagnosis: Retrograde P waves can be buried within the QRS complex OR create S-waves in inferior leads (pseudo-S waves) and apparent R waves in V1 (pseudo-R’). Typically have a short RP interval. HR is typically 180 +/- 20 bpm.
  • Treatment: AV nodal blockade (carotid sinus massage, adenosine to break the cycle, beta blockers, calcium channel blockers). If unstable or symptomatic, cardiovert.

A-V reentry tachycardia (AVRT):

  • Causes: an SVT that is generated by an accessory pathway.  A common example is Wolf-Parkinson-White (WPW) syndrome.
  • Diagnosis: short RP interval, but longer than the RP in AVNRT, retrograde P waves.
  • WPW: characterized by the presence of the delta wave, which is a broadened up sloping of the R wave.
  • Treatment: AV nodal blockade as above. In contrast to patients with atrial fibrillation and WPW, adenosine can be given to patients with AVRT.

Junctional tachycardia: Rare in adults

  • Causes: MI, digoxin toxicity, myocarditis, medication use (inotropic agents).
  • Diagnosis: rate usually 100-140 and P waves absent (buried within QRS) or seen after QRS (retrograde).
  • Treatment: treat the underlying cause. If symptomatic and it is not new, can consider beta-blockade or calcium channel blockade as with atrial flutter and fibrillation.

Four Main Causes of Irregular Narrow Complex Tachycardia

Atrial fibrillation: see Cardiology: Atrial fibrillation for details

  • Causes: very common in older individuals and in patients who are acutely ill. 
  • Diagnosis: lack of p-waves or flutter waves in all leads, irregularly irregular rhythm. Coarse Atrial Fibrillation may present with a p-wave like morphology, but the R-R intervals are irregular.
  • Treatment: treat this like sinus tachycardia - treat the underlying cause (sepsis, volume overload). If the underlying cause is being treated and patients are symptomatic from the Atrial Fibrillation (i.e. have chest pain, dyspnea, etc.) and the HR >110, you can consider rate control>rhythm control. If patients are unstable, follow ACLS and cardiovert. In patients who are stable, options include:
    • IV 5 mg of Metoprolol (up to 3-pushes, 5 minutes apart) and/or a PO dose of 12.5-25 mg.
    • IV Diltiazem can be given as 10 mg pushes.
    • If blood pressures are soft, you can use IV Amiodarone as a bolus and then drip. However, amiodarone carries the risk of chemical cardioversion, which can cause embolic stroke in a patient not on anticoagulation. 

Atrial flutter with variable AV block:

  • Causes: same as atrial fibrillation
  • Diagnosis: will look similar to AF except with the presence of flutter waves.  Often the flutter waves will be visible in the inferior leads with a rate of ~300 bpm. They are often seen in 2-3:1 block.
  • Treatment: managed similarly to atrial fibrillation, but can be very difficult to rate control. Typical atrial flutter is very responsive to EP ablation.

Multifocal atrial tachycardia (MAT): 

  • Causes: multiple ectopic atrial pacemakers, usually associated with pulmonary disease, but can also be seen in underlying ischemic cardiac disease, hypomagnesemia, and hypokalemia.
  • Diagnosis: at least 3 morphologically distinct p waves with differing PR intervals on ECG.
  • Treatment: treat the underlying cause, no role for AV nodal blockade, but verapamil may be useful to eliminate the multifocal atrial rhythm.

Frequent PACs: usually benign 

Key points

  • Sinus tachycardia is usually not treated and is a signal for an underlying problem.
  • Synchronized cardioversion and ACLS protocol for unstable SVT should not be delayed.
  • Adenosine makes patients feel terrible. Try vagal maneuvers first.
  • Adenosine is both diagnostic and therapeutic; always use continuous ECG monitoring during administration.
  • In patients with atrial fibrillation with a pre-excitation pathway (look for delta waves), avoid adenosine, which can precipitate VT or VF.
  • Atrial flutter can often be very difficult to rate control.

 

Delacretaz, E. “Supraventricular Tachycardia.” N Engl J Med 2006; 1039-1051

2015 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7.18: Tachyarrhythmias. https://eccguidelines.heart.org/circulation/cpr-ecc-guidelines/

Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med 1995;332:162-173.

Appelboam A et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet 2015; 386(100005).